Thermo Fisher Scientific | TMO - Ebitda

Stock Price
561.26
Daily Change
-3.96 -0.70%
Monthly
-8.17%
Yearly
-3.63%
Q1 Forecast
560.79

Thermo Fisher Scientific reported $3.17B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Agilent USD 466M 5M Jun/2025
Becton, Dickinson and Co. USD 2.15B 674M Sep/2025
Bio Techne USD 103.42M 7.47M Dec/2025
Bio-Rad Laboratories USD 467.2M 372.2M Jun/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Bruker USD 128.1M 27.1M Jun/2025
Charles River Laboratories USD 282.89M 64.81M Sep/2025
Danaher USD 2.13B 252M Dec/2025
Dentsply International USD 167M 30M Sep/2025
Edwards Lifesciences USD 469M 57.7M Jun/2025
Exact Sciences USD 135.42M 2.8M Sep/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Henry Schein USD 295M 39M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Illumina USD 332M 12M Sep/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Medtronic USD 2.44B 139M Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Myriad Genetics USD 10.3M 4.2M Sep/2025
Olympus JPY 50.3B 17.74B Sep/2025
Quest Diagnostics USD 561M 9M Sep/2025
Repligen USD 35.93M 3.75M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Veracyte USD 39.73M 3.96M Sep/2025
Waters USD 295.14M 18.87M Sep/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025